Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (221-230 of 403) with videos related to

Pageof 41
Sort By:
Experimental Hematology|July 26, 2011
miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemiaDmitriy Ovcharenko, Friedrich Stölzel, David Poitz, et al.
Annals of Hematology|August 12, 2016
Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5qEkaterina Balaian, Claudia Schuster, Claudia Schönefeldt, et al.
Oncoimmunology|February 6, 2014
TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunityMarc Cartellieri, Claudia Arndt, Anja Feldmann, et al.
International Journal of Cancer|May 9, 2014
Breast carcinoma cells modulate the chemoattractive activity of human bone marrow-derived mesenchymal stromal cells by interfering with CXCL12Manja Wobus, Catrin List, Tobias Dittrich, et al.
Leukemia Research|November 27, 2018
Characterization of acute myeloid leukemia with del(9q) - Impact of the genes in the minimally deleted regionIsabel S Naarmann-de Vries, Yvonne Sackmann, Felicitas Klein, et al.
Blood|September 17, 2013
CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMTMartin Schmidt-Hieber, Myriam Labopin, Dietrich Beelen, et al.
American Journal of Hematology|July 25, 2003
Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcomePhilipp Le Coutre, Karl-Anton Kreuzer, Il-Kang Na, et al.
Haematologica|May 30, 2013
Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomideRuben A Ferrer, Manja Wobus, Catrin List, et al.
Molecular Therapy Oncolytics|May 29, 2020
Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive LeukemiaSimon Loff, Josephine Dietrich, Jan-Erik Meyer, et al.
American Journal of Hematology|September 16, 2018
Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMTMaximilian Christopeit, Myriam Labopin, Norbert-Claude Gorin, et al.
Pageof 41

Showing results (221-230 of 403) with videos related to

Sort By:
Pageof 41
Experimental Hematology|July 26, 2011
miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemiaDmitriy Ovcharenko, Friedrich Stölzel, David Poitz, et al.
Annals of Hematology|August 12, 2016
Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5qEkaterina Balaian, Claudia Schuster, Claudia Schönefeldt, et al.
Oncoimmunology|February 6, 2014
TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunityMarc Cartellieri, Claudia Arndt, Anja Feldmann, et al.
International Journal of Cancer|May 9, 2014
Breast carcinoma cells modulate the chemoattractive activity of human bone marrow-derived mesenchymal stromal cells by interfering with CXCL12Manja Wobus, Catrin List, Tobias Dittrich, et al.
Leukemia Research|November 27, 2018
Characterization of acute myeloid leukemia with del(9q) - Impact of the genes in the minimally deleted regionIsabel S Naarmann-de Vries, Yvonne Sackmann, Felicitas Klein, et al.
Blood|September 17, 2013
CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMTMartin Schmidt-Hieber, Myriam Labopin, Dietrich Beelen, et al.
American Journal of Hematology|July 25, 2003
Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcomePhilipp Le Coutre, Karl-Anton Kreuzer, Il-Kang Na, et al.
Haematologica|May 30, 2013
Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomideRuben A Ferrer, Manja Wobus, Catrin List, et al.
Molecular Therapy Oncolytics|May 29, 2020
Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive LeukemiaSimon Loff, Josephine Dietrich, Jan-Erik Meyer, et al.
American Journal of Hematology|September 16, 2018
Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMTMaximilian Christopeit, Myriam Labopin, Norbert-Claude Gorin, et al.
Pageof 41